Pdf Viewer

WHO bes -practice statement on the off -label use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

World Health Organization WHO (2017) C_WHO
Source:  https://apps.who.int/iris/bitstream/10665/258941/1/WHO-HTM-TB-2017.20-eng.pdf?ua=1

The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF